Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Halocarbon Products

Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting the industry growth.

Inhalation anesthesia market size is projected to surpass USD 1.9 billion by 2025.

Request for a sample copy of this report @ https://www.gminsights.com/request-sample/detail/704

According to GMI report, Induction application segment had registered a valuation of over USD 250 million in 2018 and is expected to observe a notable growth over the forthcoming years. This can be attributed to the advantages offered by inhalation anesthesia induction in terms of improved parameters including metabolism rate of kidney/liver, Minimum Alveolar Concentration (MAC), therapeutic index of drug and patient's age and potency, etc. Moreover, induction of anesthesia requires higher concentration of drug as compared to the amount required for maintenance, which is another growth rendering factor for the segment.

Sevoflurane is experiencing an increased consumer inclination owing to its significant functionality for the treatment of pediatric patients. Rise in the product adoption is majorly due to the fact that sevoflurane can effectively be used for inhalation or gas induction with or without the inclusion of nitrous oxide. Besides, sevoflurane also offers lower blood gas solubility, non-pungent odor, and reduced effect on cerebral blood flow. In lieu of these aforementioned advantages , the segment had recorded a considerable revenue share of over 70% in 2018 and is likely to show similar growth over the ensuing years.

Hospitals segment is witnessing an accelerating demand for inhalation anesthesia on account of growing incidences of injuries and surgical procedures. Also, there has been a significant rise in the number of multispecialty hospitals equipped with advanced facilities offering effective therapeutic treatment for patients. Further, provision of cost-effective surgeries and other treatments at various government hospitals across middle-and-low income nations is likely to impel the product demand to a great extent. Given the prominence of these factors, the segment is estimated to register an appreciable CAGR of 5% over the forecast timeframe.

Asia Pacific inhalation anesthesia industry had registered a substantial revenue share of 20% in 2018 and is estimated to observe a significant growth rate over the forecast period. The growth can be attributed to enhanced patient care along with rising deployment of advanced technologies for effective patient monitoring across the regional healthcare facilities. Moreover, rising healthcare expenditure and elevating demand for surgical procedures will further enhance the business growth in Asia Pacific.

Considering rising product demand in the region, several manufacturers are emphasizing on various strategic initiatives for effectively serving the growing demand. For instance, in 2019, BioQ Pharma announced that it had received the Australian Therapeutic Goods Administration approval for its product Propofusor containing 1% propofol.

According to the company, the product is designed for maintenance and induction of general anesthesia, conscious sedation in surgical and diagnostic procedures and sedation of mechanically ventilated patients during intensive care. The company further stated that Australia boast of a wide scope for business expansion with an estimation of around 1.2 million gastrointestinal and nearly 2.5 million surgical procedures annually, which apparently will help them gain a strong presence in the market.

Prominent market players operating in inhalation anesthesia industry such as Halocarbon Products, Baxter International, Abbvie, Piramal, Hikma Pharmaceuticals, Lunan Pharmaceutical, Jiangsu Hengrui Medicine and Fresenius Kabi are focused on new product launches, geographical expansion, mergers and acquisitions to gain a strong foothold in the market.

Browse full table of contents (TOC) of this report @ https://www.gminsights.com/toc/detail/inhalation-anesthesia-market

Partial Chapter of the Table of Content

Chapter 3. Inhalation Anesthesia Industry Insights

3.1. Industry segmentation

3.2. Industry landscape, 2014 - 2025

3.3. Industry impact forces

3.3.1. Growth drivers

3.3.1.1. Surge in number of emergency cases

3.3.1.2. Growing demand for surgical procedures worldwide

3.3.1.3. Rising geriatric population susceptible to chronic diseases

3.3.1.4. Advantages of inhalation anesthetics over injectable anesthetics

3.3.2. Industry pitfalls and challenges

3.3.2.1. Side effects associated with anesthetics

3.4. Growth potential analysis

3.4.1. By product

3.4.2. By application

3.4.3. By end-use

3.5. Porter’s analysis

3.6. Competitive landscape, 2018

3.6.1. Strategy dashboard

3.7. PESTEL analysis

Chapter 4. Inhalation Anesthesia Market, By Product

4.1. Key segment trends

4.2. Sevoflurane

4.2.1. Market size, by region, 2014 – 2025 (USD Million)

4.2.2. Market size, by region, 2014 – 2025 (000’ Units)

4.3. Desflurane

4.3.1. Market size, by region, 2014-2025 (USD Million)

4.3.2. Market size, by region, 2014 – 2025 (000’ Units)

4.4. Isoflurane

4.4.1. Market size, by region, 2014 – 2025 (USD Million)

4.4.2. Market size, by region, 2014 – 2025 (000’ Units)

4.5. Others

4.5.1. Market size, by region, 2014-2025 (USD Million)

4.5.2. Market size, by region, 2014 – 2025 (000’ Units)

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.